Physician profile
Catherine B Gahn
NPI 1588815880
$2,445.63
in general payments reported to CMS, 2019-2025
11 companies · $192 in 2025
The $192 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $378 · 2022: $646 · 2023: $966 · 2024: $264 · 2025: $192.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,422.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,421.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $721.52 | 2021-2023 | Arexvy |
| Astrazeneca Pharmaceuticals LP | $679.77 | 2021-2023 | Fasenra, Tezspire |
| Jazz Pharmaceuticals INC. | $245.60 | 2024 | |
| Harmony Biosciences LLC | $180.95 | 2021-2022 | |
| Tactile Systems Technology INC | $147.20 | 2023 | Entre Plus, Flexitouch Plus |
| Boehringer Ingelheim Pharmaceuticals, INC. | $111.76 | 2025 | Jardiance |
| United Therapeutics Corporation | $97.64 | 2023 | Tyvaso |
| Novo Nordisk INC | $97.34 | 2022 | |
| Exact Sciences Corporation | $80.44 | 2025 | Cologuard Collection Kit |
| Medical Device Business Services, INC. | $64.98 | 2023 | Stratafix |
| Genentech, INC. | $18.43 | 2024 | Tnkase |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Catherine Gahn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.